| XLS |
Umsatzerlöse, operatives Ergebnis (EBIT) und Forschungs- sowie Entwicklungskosten nach Unternehmensbereichen1 |
||||||||||||||
|
|
|
|
|
|
|
|
|
||||||
In Mio. € |
|
Healthcare |
|
Life Science |
|
Performance Materials |
|
Merck-Gruppe |
||||||
|
|
|
|
|
|
|
|
|
||||||
2019 |
|
|
|
|
|
|
|
|
||||||
Umsatzerlöse |
|
6.714 |
|
6.864 |
|
2.574 |
|
16.152 |
||||||
Operatives Ergebnis (EBIT) |
|
1.149 |
|
1.280 |
|
307 |
|
2.120 |
||||||
F&E-Kosten2 |
|
1.666 |
|
276 |
|
267 |
|
2.268 |
||||||
|
|
|
|
|
|
|
|
|
||||||
2020 |
|
|
|
|
|
|
|
|
||||||
Umsatzerlöse |
|
6.639 |
|
7.515 |
|
3.380 |
|
17.534 |
||||||
Operatives Ergebnis (EBIT) |
|
1.804 |
|
1.599 |
|
240 |
|
2.985 |
||||||
F&E-Kosten2 |
|
1.640 |
|
313 |
|
274 |
|
2.288 |
||||||
|
||||||||||||||